REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Thursday reported a loss of $97.6 million in its second quarter.

The Redwood City, California-based company said it had a loss of 96 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 87 cents per share.

The provider of oncology testing services posted revenue of $92.1 million in the period, surpassing Street forecasts. Six analysts surveyed by Zacks expected $84.6 million.

Guardant Health expects full-year revenue in the range of $360 million to $370 million.

Guardant Health shares have decreased 11% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $115.25, a rise of 35% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News